Skip to main content

Abstract

The present study investigated the influence of Bacillus subtilis GCB-13-001 on growth performance, nutrient digestibility, blood characteristics, faecal microbiota and faecal score in weanling pigs. A total of 120 weaning pigs [(Landrace × Yorkshire) × Duroc; 7.73 ± 0.75 kg (28 days of age)] were randomly allotted into three treatments according to their initial body weight (BW) and gender in a 6-week experiment. There were 8 replication pens in each treatment, with five pigs/pen. Dietary treatment groups were as follows: (a) basal diet (CON), (b) CON + 0.1% Bacillus subtilis GCB-13-001 1 × 108 CFU/kg (T1) and (c) CON + 0.1% Bacillus subtilis GCB-13-001 1 × 109 CFU/kg (T2). Days 1 to 7, the BW and ADG with T2 treatment were higher (p < .05) than CON treatment, as well as F:G showed trends in linear reduction (p < .1). Days 8 to 21, the BW and ADG were improved (p < .05) in pigs offered T1 and T2 diets compared with CON diet. Days 22 to 42, BW and ADG were higher (p < .05) in pigs fed T2 diet than CON and T1 diets, and the pigs fed T1 diet had higher BW than CON treatment. Overall, the ADG with the T2 treatment was higher (p < .05) than that with the T1 and CON treatments, and pigs offered T1 treatment had higher (p < .05) ADG than CON treatment. Moreover, F:G ratio were significantly decreased (p < .05) by T2 treatment compared with CON treatment. The faecal Lactobacillus counts were improved, and E. coli counts were reduced (p < .05) in pigs fed T2 diet compared with CON at the end of the experiment. In conclusion, supplementation of 0.1% Bacillus subtilis GCB-13-001 1 × 109 CFU/kg has shown a beneficial effect in improving BW, increase ADG, decrease F:G ratio.

Keywords: Bacillus subtilis; blood profile; faecal microbial; growth performance; nutrient digestibility; weanling pigs.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Bacillus subtilis AB22Improved Fecal Microbiota CompositionBeneficial
Moderate
Bacillus subtilis AB22Improved Feed EfficiencyBeneficial
Large
Bacillus subtilis AB22Improved Nutrient DigestibilityBeneficial
Moderate
Bacillus subtilis DE111Improved Average Daily GainBeneficial
Large
Bacillus subtilis DE111Improved Feed-to-Gain RatioBeneficial
Moderate
Bacillus subtilis DE111Increased Body WeightBeneficial
Large
Bacillus subtilis DE111Increased Fecal Lactobacillus CountBeneficial
Moderate
Bacillus subtilis DE111Reduced Fecal Escherichia coli CountBeneficial
Moderate

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at support@pillser.com.